Drugs / PalinGen Flow Amniotic Tissue Allograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04667416 | Jan 2021 → Mar 2024 | ulcer of lower limbs | Amnio Technology, LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PalinGen Flow Amniotic Tissue Allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04667416 ↗ |
| Route | Subcutaneous | “by subcutaneous injection” NCT04667416 ↗ |